da-8031
Small moleculeexperimental
Clinical trial activity
2 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01104948)
Timeline
Indications
Mechanism of action
- Serotonin transporterINHIBITOR
SLC6A4 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
COc1ccc(C2(CCCN(C)C)OCc3cc(C#N)ccc32)cc1- Mol. weight
- 336.43 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095175 ↗
Also known as
- da8031
- da 8031
- da-8031
- da-8031
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01798667 | Phase 2 | Jan 1, 2013 | Catholic University of Korea, Chonbuk National University, Chonnam National University, Dong-A Pharmaceutical, Hallym University, Korea University, Pusan National University, Seoul National University, Sungkyunkwan University, University of Ulsan, Yeongnam University |
| NCT01104948 | Phase 1 | May 1, 2010 | Dong-A Pharmaceutical |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dong-A Pharmaceutical | For profit | 2 | 2 | 2 | 2010 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Chonnam National University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Hallym University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Pusan National University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Yeongnam University | Academic/Hospital | 1 | 0 | 1 | 2013 |
11 organizations
Page 1 / 1